Oversight Committee Hearing on FDA Regulations and Crises Management
According to the official website of the U.S. House of Representatives, the House Committee on Oversight and Reform will hold a hearing this week titled "Oversight of the Food and Drug Administration." Robert Califf, the Commissioner of the Food and Drug Administration, will testify and answer questions about the agency's regulation of tobacco and nicotine products.
The purpose of this hearing is to review the ongoing investigations by the oversight committee into the FDA's handling of various issues, including the infant formula crisis, food safety, drug shortages, facility inspections, cannabis regulation, tobacco and nicotine product regulation, as well as over-the-counter decongestants.
The oversight committee emphasized several crises that have occurred within the FDA's regulatory scope, pointing out that these events have had a negative impact on the lives and health of American citizens and families. Chairman of the oversight committee, James Comer, stated that they will be requesting the FDA Commissioner to explain the actions taken in response to the current crises, inspection measures to prevent nationwide crises in the future, and steps to ensure the primary protection of American consumers.
The hearing will be held on Thursday, April 11, 2024 at 1:00 PM Eastern Time, with witnesses including FDA Commissioner Dr. Robert Califf. The hearing will be open to the public and media, and will be live-streamed on https://oversight.house.gov/.
Disclaimer:
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.
